Proceedings of the Canadian frailty network summit: Medication optimization for frail older Canadians, Toronto, Monday April 24, 2017

John Muscedere; Perry Kim; Peter Aitken; Michael Gaucher; Robin Osborn; Barbara Farrell; Jayna Holroyd-Leduc; Laurie Mallery; Henry Siu; James Downar; Todd C. Lee; Emily McDonald; Lisa Burry

doi:10.5770/cgj.20.293

Proceedings of the Canadian frailty network summit: Medication optimization for frail older Canadians, Toronto, Monday April 24, 2017

John Muscedere, Perry Kim, Peter Aitken, Michael Gaucher, Robin Osborn, Barbara Farrell, Jayna Holroyd-Leduc, Laurie Mallery, Henry Siu, James Downar, Todd C. Lee, Emily McDonald, Lisa Burry

Medicine

Medicine

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

10 Citas (Scopus)

Resumen

Appropriate and optimal use of medication and polypharmacy are especially relevant to the care of older Canadians living with frailty, often impacting their health outcomes and quality of life. A majority (two thirds) of older adults (65 or older) are prescribed five or more drug classes and over one-quarter are prescribed 10 or more drugs. The risk of adverse drug-induced events is even greater for those aged 85 or older where 40% are estimated to take drugs from 10 or more drug classes. The Canadian Frailty Network (CFN), a pan-Canadian non-for-profit organization funded by the Government of Canada through the Networks of Centres of Excellence Program (NCE), is dedicated to improving the care of older Canadian living with frailty and, as part of its mandate, convened a meeting of stakeholders from across Canada to seek their perspectives on appropriate medication prescription. The CFN Medication Optimization Summit identified priorities to help inform the design of future research and knowledge mobilization efforts to facilitate optimal medication prescribing in older adults living with frailty. The priorities were developed and selected through a modified Delphi process commencing before and concluding during the summit. Herein we describe the overall approach/process to the summit, a summary of all the presentations and discussions, and the top ten priorities selected by the participants.

Idioma original	English
Páginas (desde-hasta)	253-263
Número de páginas	11
Publicación	Canadian Geriatrics Journal
Volumen	20
N.º	4
DOI	https://doi.org/10.5770/cgj.20.293
Estado	Published - dic. 2017

Nota bibliográfica

Funding Information:
1Department of Critical Care Medicine, Queen’s University and 2Canadian Frailty Network, Kingston, ON, Canada; 3Partnerships, Development and Government Relations, Canadian Frailty Network, Kingston, ON, Canada; 4Pharmaceuticals and Health Workforce Information Services, Canadian Institute of Health Information, Ottawa, ON, Canada;5International Health Policy and Practice Innovations for the Commonwealth Fund, New York, NY, U.S.A.; 6Bruyère Research Institute, Department of Family Medicine, University of Ottawa, Ottawa, ON, Canada; 7Medicine and Community Health Science, University of Calgary, Calgary, AB, Canada; 8Geriatric Medicine, Dalhousie University, Halifax, NS, Canada; 9Family Medicine at McMaster University, Hamilton, ON, Canada; 10Department of Medicine, University of Toronto, Toronto, ON, Canada; 11McGill University Health Centre, Montreal, HQ, Canada; 12Mount Sinai Hospital and the University of Toronto, Toronto, ON, Canada

Publisher Copyright:
© 2017 Author(s).

ASJC Scopus Subject Areas

Gerontology
Geriatrics and Gerontology

Acceder al documento

10.5770/cgj.20.293

Otros archivos y enlaces

Citar esto

Muscedere, J., Kim, P., Aitken, P., Gaucher, M., Osborn, R., Farrell, B., Holroyd-Leduc, J., Mallery, L., Siu, H., Downar, J., Lee, T. C., McDonald, E., & Burry, L. (2017). Proceedings of the Canadian frailty network summit: Medication optimization for frail older Canadians, Toronto, Monday April 24, 2017. Canadian Geriatrics Journal, 20(4), 253-263. https://doi.org/10.5770/cgj.20.293

Muscedere, J, Kim, P, Aitken, P, Gaucher, M, Osborn, R, Farrell, B, Holroyd-Leduc, J, Mallery, L, Siu, H, Downar, J, Lee, TC, McDonald, E & Burry, L 2017, 'Proceedings of the Canadian frailty network summit: Medication optimization for frail older Canadians, Toronto, Monday April 24, 2017', Canadian Geriatrics Journal, vol. 20, n.º 4, pp. 253-263. https://doi.org/10.5770/cgj.20.293

@article{232c5e5c1f4646d090b0fd4bbde1206d,

title = "Proceedings of the Canadian frailty network summit: Medication optimization for frail older Canadians, Toronto, Monday April 24, 2017",

abstract = "Appropriate and optimal use of medication and polypharmacy are especially relevant to the care of older Canadians living with frailty, often impacting their health outcomes and quality of life. A majority (two thirds) of older adults (65 or older) are prescribed five or more drug classes and over one-quarter are prescribed 10 or more drugs. The risk of adverse drug-induced events is even greater for those aged 85 or older where 40% are estimated to take drugs from 10 or more drug classes. The Canadian Frailty Network (CFN), a pan-Canadian non-for-profit organization funded by the Government of Canada through the Networks of Centres of Excellence Program (NCE), is dedicated to improving the care of older Canadian living with frailty and, as part of its mandate, convened a meeting of stakeholders from across Canada to seek their perspectives on appropriate medication prescription. The CFN Medication Optimization Summit identified priorities to help inform the design of future research and knowledge mobilization efforts to facilitate optimal medication prescribing in older adults living with frailty. The priorities were developed and selected through a modified Delphi process commencing before and concluding during the summit. Herein we describe the overall approach/process to the summit, a summary of all the presentations and discussions, and the top ten priorities selected by the participants.",

author = "John Muscedere and Perry Kim and Peter Aitken and Michael Gaucher and Robin Osborn and Barbara Farrell and Jayna Holroyd-Leduc and Laurie Mallery and Henry Siu and James Downar and Lee, {Todd C.} and Emily McDonald and Lisa Burry",

note = "Funding Information: 1Department of Critical Care Medicine, Queen{\textquoteright}s University and 2Canadian Frailty Network, Kingston, ON, Canada; 3Partnerships, Development and Government Relations, Canadian Frailty Network, Kingston, ON, Canada; 4Pharmaceuticals and Health Workforce Information Services, Canadian Institute of Health Information, Ottawa, ON, Canada;5International Health Policy and Practice Innovations for the Commonwealth Fund, New York, NY, U.S.A.; 6Bruy{\`e}re Research Institute, Department of Family Medicine, University of Ottawa, Ottawa, ON, Canada; 7Medicine and Community Health Science, University of Calgary, Calgary, AB, Canada; 8Geriatric Medicine, Dalhousie University, Halifax, NS, Canada; 9Family Medicine at McMaster University, Hamilton, ON, Canada; 10Department of Medicine, University of Toronto, Toronto, ON, Canada; 11McGill University Health Centre, Montreal, HQ, Canada; 12Mount Sinai Hospital and the University of Toronto, Toronto, ON, Canada Publisher Copyright: {\textcopyright} 2017 Author(s).",

year = "2017",

month = dec,

doi = "10.5770/cgj.20.293",

language = "English",

volume = "20",

pages = "253--263",

journal = "Canadian Geriatrics Journal",

issn = "1718-1879",

publisher = "Canadian Geriatrics Society",

number = "4",

}

TY - JOUR

T1 - Proceedings of the Canadian frailty network summit

T2 - Medication optimization for frail older Canadians, Toronto, Monday April 24, 2017

AU - Muscedere, John

AU - Kim, Perry

AU - Aitken, Peter

AU - Gaucher, Michael

AU - Osborn, Robin

AU - Farrell, Barbara

AU - Holroyd-Leduc, Jayna

AU - Mallery, Laurie

AU - Siu, Henry

AU - Downar, James

AU - Lee, Todd C.

AU - McDonald, Emily

AU - Burry, Lisa

N1 - Funding Information: 1Department of Critical Care Medicine, Queen’s University and 2Canadian Frailty Network, Kingston, ON, Canada; 3Partnerships, Development and Government Relations, Canadian Frailty Network, Kingston, ON, Canada; 4Pharmaceuticals and Health Workforce Information Services, Canadian Institute of Health Information, Ottawa, ON, Canada;5International Health Policy and Practice Innovations for the Commonwealth Fund, New York, NY, U.S.A.; 6Bruyère Research Institute, Department of Family Medicine, University of Ottawa, Ottawa, ON, Canada; 7Medicine and Community Health Science, University of Calgary, Calgary, AB, Canada; 8Geriatric Medicine, Dalhousie University, Halifax, NS, Canada; 9Family Medicine at McMaster University, Hamilton, ON, Canada; 10Department of Medicine, University of Toronto, Toronto, ON, Canada; 11McGill University Health Centre, Montreal, HQ, Canada; 12Mount Sinai Hospital and the University of Toronto, Toronto, ON, Canada Publisher Copyright: © 2017 Author(s).

PY - 2017/12

Y1 - 2017/12

N2 - Appropriate and optimal use of medication and polypharmacy are especially relevant to the care of older Canadians living with frailty, often impacting their health outcomes and quality of life. A majority (two thirds) of older adults (65 or older) are prescribed five or more drug classes and over one-quarter are prescribed 10 or more drugs. The risk of adverse drug-induced events is even greater for those aged 85 or older where 40% are estimated to take drugs from 10 or more drug classes. The Canadian Frailty Network (CFN), a pan-Canadian non-for-profit organization funded by the Government of Canada through the Networks of Centres of Excellence Program (NCE), is dedicated to improving the care of older Canadian living with frailty and, as part of its mandate, convened a meeting of stakeholders from across Canada to seek their perspectives on appropriate medication prescription. The CFN Medication Optimization Summit identified priorities to help inform the design of future research and knowledge mobilization efforts to facilitate optimal medication prescribing in older adults living with frailty. The priorities were developed and selected through a modified Delphi process commencing before and concluding during the summit. Herein we describe the overall approach/process to the summit, a summary of all the presentations and discussions, and the top ten priorities selected by the participants.

AB - Appropriate and optimal use of medication and polypharmacy are especially relevant to the care of older Canadians living with frailty, often impacting their health outcomes and quality of life. A majority (two thirds) of older adults (65 or older) are prescribed five or more drug classes and over one-quarter are prescribed 10 or more drugs. The risk of adverse drug-induced events is even greater for those aged 85 or older where 40% are estimated to take drugs from 10 or more drug classes. The Canadian Frailty Network (CFN), a pan-Canadian non-for-profit organization funded by the Government of Canada through the Networks of Centres of Excellence Program (NCE), is dedicated to improving the care of older Canadian living with frailty and, as part of its mandate, convened a meeting of stakeholders from across Canada to seek their perspectives on appropriate medication prescription. The CFN Medication Optimization Summit identified priorities to help inform the design of future research and knowledge mobilization efforts to facilitate optimal medication prescribing in older adults living with frailty. The priorities were developed and selected through a modified Delphi process commencing before and concluding during the summit. Herein we describe the overall approach/process to the summit, a summary of all the presentations and discussions, and the top ten priorities selected by the participants.

UR - http://www.scopus.com/inward/record.url?scp=85040113792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040113792&partnerID=8YFLogxK

U2 - 10.5770/cgj.20.293

DO - 10.5770/cgj.20.293

M3 - Article

AN - SCOPUS:85040113792

SN - 1718-1879

VL - 20

SP - 253

EP - 263

JO - Canadian Geriatrics Journal

JF - Canadian Geriatrics Journal

IS - 4

ER -

Proceedings of the Canadian frailty network summit: Medication optimization for frail older Canadians, Toronto, Monday April 24, 2017

Resumen

Nota bibliográfica

ASJC Scopus Subject Areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto